
Shares of drugmaker Catalyst Pharmaceuticals CPRX.O rise 7.9% to $22.21
Company late on Wednesday forecast 2025 revenue in the range of $545 million to $565 millionn, analysts on average expect revenue to be $556.9 million, as per data compiled by LSEG
CPRX posted fourth-quarter revenue of $141.8 million, beating analysts' estimate of $134.2 million
Reported adj quarterly profit of 70 cents/share vs analysts' estimate of 34 cents/share
Stock has risen 41.1% in the past 12 months